Financials
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25Q4, 25 TTM Selling/general/admin expenses 530 M544 M543 M526 M545 M549 M 2.16 B Research & development —————— — Operating income 644 M669 M488 M526 M513 M331 M 1.86 B Non-Operating Income, Total 592 M626 M575 M578 M577 M576 M 2.31 B Interest expense, net of interest capitalized 616 M10 M582 M587 M582 M1 M 1.75 B Non-Operating Income, excl. Interest Expenses -28 M620 M-8 M-10 M-8 M578 M 552 M Unusual income/expense 4 M-4 M1 M1 M3 M-3 M 2 M Pretax income 620 M176 M481 M517 M512 M506 M 2.02 B Equity in earnings —————— — Taxes 43 M19 M11 M13 M25 M-38 M 11 M Non-controlling/minority interest 18 M13 M17 M17 M16 M15 M 65 M After tax other income/expense 11 M-12 M1 M007 M 8 M Net income before discontinued operations 9 M-11 M115 M82 M55 M250 M 502 M Discontinued operations —————— — Net income 9 M-11 M115 M82 M55 M250 M 502 M Dilution adjustment —————— — Preferred dividends —————— — Diluted net income available to common stockholders 9 M-11 M115 M82 M55 M250 M 502 M Basic earnings per share (Basic EPS) -0.040.04-0.54-0.39-0.27-1.22 -2.42 Diluted earnings per share (Diluted EPS) -0.040.04-0.54-0.39-0.27-1.22 -2.42 Average basic shares outstanding 215 M215 M212 M209 M207 M208 M 836 M Diluted shares outstanding 215 M215 M212 M209 M207 M208 M 836 M EBITDA —————— — EBIT —————— — Cost of revenue —————— — Other cost of goods sold —————— — Depreciation & amortization (cash flow) 326 M345 M357 M364 M352 M344 M 1.42 B